XTL Biopharmaceuticals Ltd. Stock Analysis & AI Score
XTL Biopharmaceuticals Ltd. (XTLB) has an ST Score of 28.3 (C-), driven by its Profitability (B) and held back by its Growth (F). Analysts rate it Buy.
Composite rating from 8 factors. Tap a factor to see the metrics behind its grade.
Company Information
| Employees | — |
| CEO | — |
| Sector | Healthcare |
| Industry | Biotechnology |
| IPO Date | — |
| Website | — |
| Country | — |
| Exchange | NASDAQ |
SEC Filings
Annual Report (10-K)
| Filing Date | Accepted | Link |
|---|---|---|
| Loading… | ||
Quarterly Report (10-Q)
| Filing Date | Accepted | Link |
|---|---|---|
| Loading… | ||
ST Score
XTL Biopharmaceuticals Ltd. (XTLB) has an ST Score of 28.3 (C-), driven by its Profitability (B) and held back by its Growth (F). Analysts rate it Buy.
- Strongest
- ProfitabilityB
- Weakest
- GrowthF
All factor grades
- ProfitabilityB
- Financial StrengthC-
- MomentumC-
- ValuationD+
- GrowthF
- Piotroski2/9
Contact
XTLB stock: frequently asked questions
What is XTLB's ST Score?
XTL Biopharmaceuticals Ltd. (XTLB) has an ST Score of 28.3 (C-), on our 0–100 scale where higher is stronger. The ST Score combines eight factor grades — valuation, profitability, financial strength, momentum, growth, forecast, sentiment and Piotroski — into a single A+ to F rating.
Is XTLB a buy, hold, or sell?
Analysts rate XTLB a Buy. Our ST Score grades it C- (28.3/100). The ST Score is a data-driven signal, not a recommendation.
What are XTLB's factor grades?
Valuation D+, Profitability B, Financial Strength C-, Momentum C-, Growth F.
What is XTLB's valuation grade?
XTL Biopharmaceuticals Ltd. (XTLB) earns a valuation grade of D+, measured against Biotechnology peers. The valuation factor looks at multiples such as P/E, P/S, P/B, EV/EBITDA and free cash flow yield.
What is XTLB's growth grade?
XTL Biopharmaceuticals Ltd. (XTLB) earns a growth grade of F, measured against Biotechnology peers. The growth factor looks at revenue, earnings and cash flow growth over recent quarters and years.
What is XTLB's profitability grade?
XTL Biopharmaceuticals Ltd. (XTLB) earns a profitability grade of B, measured against Biotechnology peers. The profitability factor looks at margins and returns such as gross margin, net margin, ROE and ROIC.
What is XTLB's financial strength grade?
XTL Biopharmaceuticals Ltd. (XTLB) earns a financial strength grade of C-, measured against Biotechnology peers. The financial strength factor looks at debt levels, liquidity and coverage ratios.
What is XTLB's Piotroski score?
XTL Biopharmaceuticals Ltd. (XTLB) has a Piotroski F-Score of 2 out of 9. The Piotroski score checks nine accounting signals covering profitability, leverage and operating efficiency; scores of 8–9 are considered strong and 0–2 weak.